CARLA FRAZINE: Open Payments
NPI 1417153982 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 94 payments from 19 companies in 2025. Trend: 2023 $955 · 2024 $1,812 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $306 |
| ABBVIE INC. | 24 | $255 |
| AstraZeneca Pharmaceuticals LP | 6 | $168 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Lilly USA, LLC | 5 | $93 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Phathom Pharmaceuticals, Inc. | 7 | $74 |
| PFIZER INC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
Products named: Wegovy, UBRELVY, BREZTRI, QULIPTA, Ozempic, Rybelsus, MOUNJARO, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
